Great leaps forward in medicine and science are expected when marijuana is officially Schedule 3.
[...]
That’s likely to happen if hospitals, universities, or even cannabis companies find that rescheduling isn’t moving science along, said Shane Pennington, a partner at national law firm Blank Rome who, along with collaborator Matt Zorn, drew attention to the limitations included in the research bill.
“Everybody wants that research done,” he told MJBizDaily. “I don’t think anyone intended the (Biden bill) to cripple research. That was not the intent.”
“I am sure that one way or the other this is going to make massive headway with research.”
To read the full article, please click here.
"Great Leaps in Cannabis Research Expected After Marijuana Rescheduling," by Chris Roberts was published in MJBizDaily on December 29, 2025.
